Burn Scar Appearance After Treatment With Fractional Carbon Dioxide (CO2) Laser

This study has been completed.
Information provided by:
Moy-Fincher Medical Group
ClinicalTrials.gov Identifier:
First received: August 29, 2009
Last updated: July 24, 2011
Last verified: July 2011

The purpose of this study is to determine if fractional carbon dioxide laser treatment of a burn scar is a more effective method for improving the appearance of scars than the current available treatments.

Condition Intervention
Device: Lumenis fractional carbon dioxide laser

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Burn Scar Characteristics After Treatment With Fractional CO2 Laser: A Clinical and Histological Study

Resource links provided by NLM:

Further study details as provided by Moy-Fincher Medical Group:

Primary Outcome Measures:
  • Evidence of clinical improvement of burn scar appearance as determined by blinded-observer and patient ratings. [ Time Frame: 2 weeks after each procedure ] [ Designated as safety issue: No ]

Estimated Enrollment: 20
Study Start Date: December 2009
Study Completion Date: December 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Laser treatment
Half of each subject's scar will be treated with a fractional CO2 laser.
Device: Lumenis fractional carbon dioxide laser
Laser resurfacing of a burn scar
Other Name: Lumenis
No Intervention: No treatment
Half of each subject's scar will not be treated.


Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Have a mature burn scar and desire revision
  • Fluent in English
  • Must reside in the Los Angeles vicinity for the duration of the study

Exclusion Criteria:

  • Previous history of scar revision
  • Non-English speakers
  • Pregnant or cognitively impaired subjects
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00969215

United States, California
Moy-Fincher Medical Group
Los Angeles, California, United States, 90095
Sponsors and Collaborators
Moy-Fincher Medical Group
Principal Investigator: David Ozog, MD Moy-Fincher Medical Group
  More Information

No publications provided

Responsible Party: Ronald Moy, MD, Moy-Fincher Medical Group
ClinicalTrials.gov Identifier: NCT00969215     History of Changes
Other Study ID Numbers: MF-02
Study First Received: August 29, 2009
Last Updated: July 24, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Moy-Fincher Medical Group:
burn scar
fractional carbon dioxide laser
scar revision

Additional relevant MeSH terms:
Pathologic Processes

ClinicalTrials.gov processed this record on April 17, 2014